Nikhil Khushalani, MD

Vice Chair for the Department of Cutaneous Oncology
H. Lee Moffitt Cancer Center, Tampa, FL, USA, United States

Presentation(s):

• 64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study

  Friday, March 24, 2023
  11:34 AM – 11:44 AM

  Disclosure information not submitted.